Laurent Essioux

17.0k total citations
32 papers, 1.7k citations indexed

About

Laurent Essioux is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Laurent Essioux has authored 32 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Genetics and 7 papers in Oncology. Recurrent topics in Laurent Essioux's work include BRCA gene mutations in cancer (5 papers), Genetic Associations and Epidemiology (5 papers) and Genomic variations and chromosomal abnormalities (5 papers). Laurent Essioux is often cited by papers focused on BRCA gene mutations in cancer (5 papers), Genetic Associations and Epidemiology (5 papers) and Genomic variations and chromosomal abnormalities (5 papers). Laurent Essioux collaborates with scholars based in Switzerland, France and United States. Laurent Essioux's co-authors include Daniel Cohen, Marta Blumenfeld, M. Daniele Fallin, Ilya Chumakov, Nicholas J. Schork, Pierre Bougnères, Christine Dos Santos, M. Tauber, Vincent Goffin and Cécile Teinturier and has published in prestigious journals such as Nucleic Acids Research, Nature Genetics and Bioinformatics.

In The Last Decade

Laurent Essioux

32 papers receiving 1.6k citations

Peers

Laurent Essioux
M. Lau United States
Mohammed Al Balwi Saudi Arabia
M Girard France
Ayumi Takakura United States
Laurent Essioux
Citations per year, relative to Laurent Essioux Laurent Essioux (= 1×) peers Pascale Cochaux

Countries citing papers authored by Laurent Essioux

Since Specialization
Citations

This map shows the geographic impact of Laurent Essioux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurent Essioux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurent Essioux more than expected).

Fields of papers citing papers by Laurent Essioux

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurent Essioux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurent Essioux. The network helps show where Laurent Essioux may publish in the future.

Co-authorship network of co-authors of Laurent Essioux

This figure shows the co-authorship network connecting the top 25 collaborators of Laurent Essioux. A scholar is included among the top collaborators of Laurent Essioux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurent Essioux. Laurent Essioux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Naidoo, Jarushka, Gonzalo Durán-Pacheco, Vidya Maiya, et al.. (2023). 2032MO Correlation of safety and efficacy in atezolizumab therapy across indications. Annals of Oncology. 34. S1079–S1079. 1 indexed citations
2.
Scheerens, Heleen, Zachary Boyd, Vivek P. Gupta, et al.. (2017). Current Status of Companion and Complementary Diagnostics: Strategic Considerations for Development and Launch. Clinical and Translational Science. 10(2). 84–92. 81 indexed citations
4.
Augustin, Angélique, Jens Lamerz, Hélène Meistermann, et al.. (2013). Quantitative Chemical Proteomics Profiling Differentiates Erlotinib from Gefitinib in EGFR Wild-Type Non–Small Cell Lung Carcinoma Cell Lines. Molecular Cancer Therapeutics. 12(4). 520–529. 16 indexed citations
5.
Lamerz, Jens, Berthold Gierke, Markus F. Templin, et al.. (2013). Multiple Protein Analysis of Formalin-fixed and Paraffin-embedded Tissue Samples with Reverse phase Protein Arrays. Molecular & Cellular Proteomics. 12(9). 2615–2622. 27 indexed citations
7.
Masson, Patrick, Chantal Hulo, Edouard de Castro, et al.. (2012). ViralZone: recent updates to the virus knowledge resource. Nucleic Acids Research. 41(D1). D579–D583. 39 indexed citations
8.
Bansal, Aruna T., Søren Germer, Ryma Benayed, et al.. (2012). Genome-wide association analysis implicates the involvement of eight loci with response to tocilizumab for the treatment of rheumatoid arthritis. The Pharmacogenomics Journal. 13(3). 235–241. 39 indexed citations
9.
Krintel, Sophine Boysen, Giuseppe Palermo, Julia S. Johansen, et al.. (2012). Investigation of single nucleotide polymorphisms and biological pathways associated with response to TNFα inhibitors in patients with rheumatoid arthritis. Pharmacogenetics and Genomics. 22(8). 577–589. 50 indexed citations
10.
Tan, E.H., Rodryg Ramlau, A Płużańska, et al.. (2010). A multicentre phase II gene expression profiling study of putative relationships between tumour biomarkers and clinical response with erlotinib in non-small-cell lung cancer. Annals of Oncology. 21(2). 217–222. 35 indexed citations
11.
Grinyó, Josep M., Yves Vanrenterghem, Björn Nashan, et al.. (2008). Association of four DNA polymorphisms with acute rejection after kidney transplantation. Transplant International. 21(9). 879–891. 94 indexed citations
12.
Tan, Eng-Huat, Rodryg Ramlau, A Płużańska, et al.. (2007). D2-04: MERIT: a prospective study of putative relationships between tumour biomarkers and clinical benefit from erlotinib in advanced non-small cell lung cancer (NSCLC). Journal of Thoracic Oncology. 2(8). S394–S395. 5 indexed citations
13.
Santos, Christine Dos, Laurent Essioux, Cécile Teinturier, et al.. (2004). A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone. Nature Genetics. 36(7). 720–724. 247 indexed citations
14.
Jannot, Anne‐Sophie, Laurent Essioux, & Françoise Clerget‐Darpoux. (2004). Association in Multifactorial Traits: How to Deal with Rare Observations?. Human Heredity. 58(2). 73–81. 7 indexed citations
15.
Zhao, Jing Hua, et al.. (2002). GENECOUNTING: haplotype analysis with missing genotypes. Bioinformatics. 18(12). 1694–1695. 98 indexed citations
16.
Essioux, Laurent, Olga M. Sinilnikova, François Eisinger, et al.. (1998). Marker segregation information in breast/ovarian cancer genetic counseling: Is it still useful?. American Journal of Medical Genetics. 79(3). 175–183. 4 indexed citations
17.
Stoppa‐Lyonnet, Dominique, Pierre Laurent‐Puig, Laurent Essioux, et al.. (1997). BRCA1 sequence variations in 160 individuals referred to a breast/ovarian family cancer clinic. Institut Curie Breast Cancer Group.. PubMed. 60(5). 1021–30. 110 indexed citations
18.
Chaffanet, Max, Laurent Essioux, Tetsuro Noguchi, et al.. (1996). Integrated Map of the Chromosome 8p12–p21 Region, a Region Involved in Human Cancers and Werner Syndrome. Genomics. 32(1). 29–38. 31 indexed citations
19.
Essioux, Laurent, et al.. (1995). Genetic epidemiology of breast cancer: interest of survival analysis methods. Annals of Human Genetics. 59(3). 271–282. 7 indexed citations
20.
Charcosset, Alain & Laurent Essioux. (1994). The effect of population structure on the relationship between heterosis and heterozygosity at marker loci. Theoretical and Applied Genetics. 89-89(2-3). 336–343. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026